Prenatal exposure to malaria may determine disease susceptibility early in life

November 01, 2018

Prenatal exposure to malaria considerably alters the newborn's innate immune response (i.e. its first line of defence), particularly when the placenta has been infected, according to a study led by ISGlobal - an institution supported by "la Caixa" Foundation-, the Clinical Research Unit of Nanoro (CRUN) and the Institute of Tropical Medicine Antwerp (ITM). The results, published in BMC Medicine, could help explain why some babies are more susceptible to malaria than others during their first year of life.

Despite the large-scale implementation of intermittent preventive treatment (IPTp) to avoid malaria during pregnancy, a great number of babies in endemic countries are born to mothers with infection by Plasmodium falciparum. The type of prenatal exposure to malaria (whether the infection is systemic or in the placenta) is believed to affect the risk of developing disease in the first years of life, although the mechanisms are poorly understood.

In this study, the research team evaluated whether prenatal exposure to malaria could lead to changes in the so-called innate immune response, which does not involve antibodies and represents the new-borns' first line of defence against malaria. To do so, the researchers determined the type of prenatal exposure (i.e. systemic infection versus acute, chronic or past placental infection) in a cohort with over 300 mothers and their babies that had participated in a clinical trial in Burkina Faso. Using cord blood, they assessed the production of cytokines and chemokines (mediators of the immune system) upon incubation with a series of molecules that are common to many pathogens and recognised by cells from the innate immune system.

They found that blood cord cells from babies exposed to malaria produced less mediators when non-stimulated, as compared to unexposed babies. However, cells from babies exposed to past placental infection were hyper-reactive upon stimulation. Certain biomarkers were associated with protection while others were associated with malaria risk during the first year of life. "The different effect on the newborn's immune response depending on the type of exposure may explain why some babies are more susceptible than others to developing malaria," explains Carlota Dobaño, ISGlobal researcher and co-director of the study together with Anna Rosanas-Urgell, from ITM. "This may also have implications regarding how these babies respond to other infections or to vaccines that contain adjuvants", she adds.

Given that past placental malaria, which potentially occurs early during pregnancy, has a profound effect on the newborn's immune response, the authors conclude "a strategy to screen and treat malaria should be implemented as early as possible in the first trimester."

Barcelona Institute for Global Health (ISGlobal)

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to